Should the FDA reconsider antidepressant boxed warnings?
UC expert featured in Medscape article
The University of Cincinnati's Jeffrey Strawn, MD, spoke with Medscape about whether the Food and Drug Administration should reevaluate boxed warnings on antidepressants linking the medications to an increased risk for suicidal thoughts and behaviors in young people.
The warnings have been in place for almost two decades, but evidence suggests they may have led to fewer depression diagnoses, reduced prescriptions and higher suicide rates.
Strawn said there was not as much data on the risks and benefits of antidepressants in youth when the warnings were instituted, but the current evidence suggests it's time to reevaluate the warnings.
“I don’t think that they’ve been useful. They’ve actually been harmful,” Strawn, professor in the Department of Psychiatry and Behavioral Neuroscience in UC’s College of Medicine and a UC Health child and adolescent psychiatrist, told Medscape Medical News. “These boxed warnings have decreased physicians’ and other clinicians’ comfort and tendency to prescribe.”
Featured photo at top of medication spilling out of a bottle with a warning symbol in the background. Photo/Arthit Pornpikanet/iStock.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.